Brief: Spectral Medical Announces U.S. FDA Approval Of DIMI Trial Protocol Amendment

Spectral Medical

31/01/2022 13:41

Jan 31 (Reuters) - Spectral Medical Inc  EDT.TO :
    * SPECTRAL MEDICAL ANNOUNCES U.S. FDA APPROVAL OF DIMI TRIAL
PROTOCOL AMENDMENT
    * SPECTRAL MEDICAL INC - ITS UNIT DIALCO MEDICAL RECEIVED
APPROVAL
OF PROTOCOL AMENDMENT TO ITS DIMI USABILITY TRIAL FROM U.S. FDA
    * SPECTRAL MEDICAL INC - THIS PROTOCOL AMENDMENT ALLOWS FOR
BOTH
IMPROVED PATIENT AND CLINICAL LOGISTICS FLOW IN CONDUCTING DIMI
TRIAL
    * SPECTRAL MEDICAL INC - IS PROGRESSING WITH CONTRACTING
CLINICAL
TRIAL SITES AND TRIAL WILL INCLUDE 35 PATIENTS IN UNITED STATES

Source text for Eikon:  ID:nGNX9Kxz9R 
Further company coverage:  EDT.TO 

 ((Reuters.Briefs@thomsonreuters.com;))